Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 20, 1997

View Archived Issues

NCI study indicates potential teratogenicity of AZT

Abbott isolates fusacandin antifungal agents

Daikin synthesizes new ganglioside compounds

New ACAT inhibitors claimed by DuPont Merck

Heterocyclic MDR inhibitors reported by Pfizer

Mayo Foundation reports new natriuretic peptide

Anti-IL-2 monoclonal antibody described by Ajinomoto

More antiobesity proteins in the pipeline at Lilly

cAMP PDE inhibitors disclosed by Nippon Kayaku

Aquila adjuvant shows promise as component of malaria vaccine

New wound-healing agents reported

New amylin antagonists from Amylin

Faulding expands into Europe

Phase II trials begin on ICOS MS treatment

EntreMed licenses dual cytotoxic/antiangiogenic compound

Troglitazone price-listed in Japan

JT to launch new imaging agent soon in Japan

Takeda claims new approach to diabetes Rx

Triangle reports preliminary clinical results with anti-HIV compound

Mochida claims new formulation for ulinastatin

IVAX and Knoll modify European alliance

Adeza obtains clearance for supplementary PMA

Forbes files for U.S. patent related to membrane deficiencies

Zeneca's right to sell prostate cancer drug upheld

Medtronic's arrhythmia management device enters clinic

Olopatadine studied for allergic conjunctivitis

BMS antidepressant chosen for important multiinstitutional trial

Ibopamine efficacy in patients with chronic progressive renal failure

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...